How much is Medicenna Therapeutics worth in 2026?

Medicenna Therapeutics has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Medicenna Therapeutics raised?

Medicenna Therapeutics has raised N/A in total funding across 1 funding rounds.

Medicenna Therapeutics

Biotechnology

Medicenna Therapeutics valuation and funding history | Last updated: April 30, 2024 | 1 funding rounds

Current Valuation

N/A

As of April 30, 2024

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$14.6M

Last Funding

Apr 2024

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
April 30, 2024	PIPE	$14.6M	N/A	-

Valuation Analysis

Current Valuation Metrics

Medicenna Therapeutics is currently valued at N/A as of April 30, 2024.

Track Medicenna Therapeutics Valuation Updates

Get notified when Medicenna Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Medicenna Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Medicenna Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Medicenna Therapeutics Worth in 2026?

Medicenna Therapeutics is a leading private company in the Biotechnology sector. Track Medicenna Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Medicenna Therapeutics Valuation is Determined

Private company valuations like Medicenna Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.